Transparency Downfall of Jose Baselga Respected Cancer Researcher Due to Careless… Thomas Sullivan Sep 18, 2018 0 Some of our readers may be familiar with Jose Baselga, MD, PhD, the former Physician-in-Chief at the Memorial Sloan Kettering…
AMA New Study Shows EHRs Can Be Beneficial, But Need Improvement Thomas Sullivan Sep 17, 2018 0 A new study involving clinicians who use electronic health records (EHRs) to perform certain common tasks provides compelling…
CMS CMS Adds Option of Step Therapy for Medicare Plans Thomas Sullivan Sep 14, 2018 0 On August 7, 2018, the Centers for Medicare & Medicaid Services (CMS) announced it will provide Medicare Advantage plans the…
Anti Kickback Sanofi Agrees to Pay $25.2 Million to Resolve FCPA Violations Thomas Sullivan Sep 13, 2018 0 On Tuesday, September 4, 2018, Sanofi agreed to pay more than $25 million to resolve charges that its Middle Eastern and…
Congress Text Books from Pharma to Doctors – “Direct Patient Education”? Thomas Sullivan Sep 13, 2018 0 Transparency is always a hot topic, and a recent tweet by Allan Coukell brought the issue to the forefront once again. The…
FDA FDA to Study Disclosures in Prescription Drug Advertisements Thomas Sullivan Sep 12, 2018 0 The United States Food and Drug Administration (FDA) laid out plans in an August 9, 2018, Federal Register publication to conduct…
Congress House E&C Health Subcommittee Advances Six Bipartisan Proposals Thomas Sullivan Sep 11, 2018 0 On Wednesday, September 5th, the House Energy & Commerce Subcommittee on Health held a hearing, “Opportunities to Improve…
Congress Senate Expected to Vote on Opioid Legislation includes Expansion of Open… Thomas Sullivan Sep 10, 2018 0 Last Thursday, Senate leaders announced that they had reached an agreement to bring a package of bills to address the nation's…
Drug Prices Prescription Copays More Expensive Than Full Price? Thomas Sullivan Sep 7, 2018 0 A study published this year by the University of Southern California’s Schaeffer Center for Health Policy and Economics,…
DOJ AstraZeneca Agrees to Settle Off-Label Marketing Suits Thomas Sullivan Sep 6, 2018 0 Recently, AstraZeneca Plc agreed to pay $110 million to settle two Texas claims that alleged the company cheated Texas’ Medicaid…